shortagewatch

Home / Respiratory system / Opium Derivatives and Expectorants

ATC R05FA02 · Opium Derivatives and Expectorants

Opium Derivatives and Expectorants shortage

As of 2 Nov 2026, Opium Derivatives and Expectorants has a reported shortage in 2 of the 16 countries we track (Canada, Norway), covering 4 products from 4 companies.

Countries2/16
Products4packs or presentations
Companies42 listed
Short since11 Apr 201412.6 years ago
Earliest return18 Dec 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada3 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorway1 product shortSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

CanadaNorway
20222023202420252026PULMORPHAN (250 ml)PULMORPHAN (250 ml)DIMETANE EXPECTORANT DC (1 Litre)DIMETANE EXPECTORANT DC (1 Litre)ROBITUSSIN AC (1 L)ROBITUSSIN AC (1 L)Solvipect Comp 2,5 mg/ml/5 mg/ml mikstur, opSolvipect Comp 2,5 mg/ml/5 mg/ml mikstur, oppløsning, 100 ml flaske av glasstoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Laboratoire Riva1Pfizer1 PFEGSK1 GSKOrifarm1

Listed: Pfizer PFE · NYSE, GSK GSK · LSE

Affected products

CountryProductCompanySinceExpected backReason
CAPULMORPHAN (250 ml)LABORATOIRE RIVA INC11 Apr 2014not givenManufacturing problem
Disruption of the manufacture of the drug
CADIMETANE EXPECTORANT DC (1 Litre)PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC5 Oct 2020not givenManufacturing problem
Disruption of the manufacture of the drug
CAROBITUSSIN AC (1 L) discontinuationGLAXOSMITHKLINE CONSUMER HEALTHCARE ULC1 Jun 2023not givenOther
Other (Please describe in comments)
NOSolvipect Comp 2,5 mg/ml/5 mg/ml mikstur, oppløsning, 100 ml flaske av glassOrifarm Healthcare A/S22 Jun 202618 Dec 2026Regulatory or licensing
Regulatoriske problemer/utfordringer

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.